The impact of genetic diversity among Akkermansia strains on the effectivenes of immune checkpoint inhibitors in cancer immunotherapies
The impact of genetic diversity among Akkermansia strains on the effectivenes of immune checkpoint inhibitors in cancer immunotherapies
批准号:
10115682
负责人:
You-Wen He
金额:
$22.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2022-02-28
关键词:
Anaerobic BacteriaAnimalsBiologicalCancer ModelCancer PatientChildClinicalCollectionDiabetes MellitusEffectivenessEngineeringEpithelial Cell JunctionFoundationsGastrointestinal tract structureGeneticGenetic VariationGenomeGenomic SegmentGerm-FreeGoalsHospitalsHumanImmune checkpoint inhibitorImmunityImmunizationImmunologic AdjuvantsImmunotherapyInsertional MutagenesisLinkMalignant NeoplasmsMetabolicMetabolic DiseasesMetastatic Renal Cell CancerMicrobeMicrobial BiofilmsMolecular GeneticsMonitorMucinsMucositisMusMutationNeoadjuvant TherapyNon-Small-Cell Lung CarcinomaObesityOrganismOutcomePD-1/PD-L1PatientsPhenotypePlayProbioticsProductionRenal Cell CarcinomaRoleSamplingSignal TransductionSourceSpecimenSurveysTestingTherapeuticTimeTransplantationTumor Cell LineVariantanti-PD-1basebeneficial microorganismcancer immunotherapycheckpoint therapycohortcomparative genomicsdefined contributiondesigndiet-induced obesitygenomic locusgerm free conditiongut colonizationimmune healthimproved outcomeinterestintestinal barriermicrobialmicrobiotamouse modelmutantpatient populationresponsestool samplesuccesstooltraittumor
中文摘要
文摘:
英文摘要
ABSTRACT:
Microbes in the gastrointestinal tract (GI) play a critical role in maintaining the metabolic
and immunological health of their human hosts. The impact of the microbiota on local
and systemic immunity is being increasingly recognized as an important modifier of the
success of immunotherapies, including those directed against cancers. For instance,
germ free animals colonized with microbiotas derived from cancer patients that
responded (responders - R) to immune checkpoint inhibitors (ICI) displayed enhanced
clearance of tumors upon ICI therapy as compared to animal colonized with microbiotas
derived from patients that did not respond (non responders - NR). One of the organisms
that is consistently associated with R patients is the obligate anaerobic bacterium
Akkermansia muciniphila, which may contribute to dampening mucosal inflammation
and regulating systemic immunity. Importantly for cancer immunotherapy, administration
of A. muciniphila is sufficient to enhance the effectiveness of ICIs in mouse models of
renal cell carcinomas (RCC) and non-small cell lung cancers. We propose to survey the
diversity of clinical A. muciniphila isolates in two unique patient populations (one
focused on cancer and one on metabolic disease), test their impact in mouse models of
cancer immunotherapy, and apply new tools in Akkermansia molecular genetics to
define the contribution of various A. muciniphila factor(s) on successful anti-tumor
therapy.
We expect that by the end of this study that we will have identified strains with the
greatest potential for use as “adjuvants” of ICI and defined the genetic basis of some of
the traits responsible for their enhanced activities. Given the current commercial interest
on Akkermansia as a probiotic, we envision a relatively rapid path from strain
identification and/or engineering to a biological that can be fast-tracked for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy in T lymphocyte function
-
批准号:7812172
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
A novel pathway regulating cytokine production and asthma development
-
批准号:7356481
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
A novel pathway regulating cytokine production and asthma development
-
批准号:7843494
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
Autophagy in T lymphocyte function
-
批准号:8461210
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
Autophagy in T lymphocyte function
-
批准号:8260354
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
Autophagy in T lymphocyte function
-
批准号:8050675
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
Autophagy in T lymphocyte function
-
批准号:7590040
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:You-Wen He
-
依托单位:
BcI-2 family in T lymphocyte homeostasis
-
批准号:8389558
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Function of thymic epithelial cells in T lymphocyte maturation
-
批准号:7686243
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
BcI-2 family in T lymphocyte homeostasis
-
批准号:7580414
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Regulation of thymocyte maturation and mature T lymphocyte homeostasis by c-FLIP
-
批准号:7372851
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
BcI-2 family in T lymphocyte homeostasis
-
批准号:7995240
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
BcI-2 family in T lymphocyte homeostasis
-
批准号:8196843
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Regulation of thymocyte maturation and mature T lymphocyte homeostasis by c-FLIP
-
批准号:8223242
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Regulation of thymocyte maturation and mature T lymphocyte homeostasis by c-FLIP
-
批准号:8014937
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Regulation of thymocyte maturation and mature T lymphocyte homeostasis by c-FLIP
-
批准号:7576734
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
BcI-2 family in T lymphocyte homeostasis
-
批准号:7739453
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Function of thymic epithelial cells in T lymphocyte maturation
-
批准号:7356899
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Regulation of thymocyte maturation and mature T lymphocyte homeostasis by c-FLIP
-
批准号:7763205
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2008
-
负责人:You-Wen He
-
依托单位:
Pattern Recognition Molecule Mindin As Adjuvant
-
批准号:7028349
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2005
-
负责人:You-Wen He
-
依托单位:
海外基金